期刊
JOURNAL OF IMMUNOLOGY
卷 189, 期 7, 页码 3714-3723出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1201594
关键词
-
类别
资金
- National Institutes of Health [RO1 HL065095, AR050800, AI42269, K23 AR055672]
- Target Identification in Lupus Grant/Alliance for Lupus Research Foundation
- Consejo Nacional de Ciencia y Tecnologia
- Fundacion Mexico en Harvard
- Arthritis Foundation
- Japan Society for the Promotion of Science
- Novartis Foundation
Systemic lupus erythematosus (SLE) is a chronic, multiorgan inflammatory autoimmune disorder associated with high levels of circulating autoantibodies and immune complexes. We report that passive transfer of human SLE sera into mice expressing the uniquely human Fc gamma RIIA and Fc gamma RIIIB on neutrophils induces lupus nephritis and in some cases arthritis only when the mice additionally lack the CD18 integrin, Mac-1. The prevailing view is that Mac-1 on macrophages is responsible for immune complex clearance. However, disease permitted by the absence of Mac-1 is not related to enhanced renal immune complex deposition or in situ C1q/C3 complement activation and proceeds even in the absence of macrophages. Instead, disease is associated with increased Fc gamma RIIA-induced neutrophil accumulation that is enabled by Mac-1 deficiency. Intravital microscopy in the cremasteric vasculature reveals that Mac-1 mitigates Fc gamma RIIA-dependent neutrophil recruitment in response to deposited immune complexes. Our results provide direct evidence that human SLE immune complexes are pathogenic, demonstrate that neutrophils are primary mediators of end organ damage in a novel humanized lupus mouse model, and identify Mac-1 regulation of Fc gamma RIIA-mediated neutrophil recruitment as a key step in development of target organ damage. The Journal of Immunology, 2012, 189: 3714-3723.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据